International Neuropsychological Society (INS)
51^st Annual Meeting in San Diego, Calif. (Feb. 1-4, 2023)

• McCauley SR, York MK, Strutt AM, Stinson JM, Henry SK, Windham VA, et al. Psychometric properties of the Verbal Series Attention Test: Preliminary findings. Presented at the International Neuropsychological Society (INS), 51^st Annual Meeting in San Diego, Calif. (Feb. 1-4, 2023).   [View poster]

Baylor College of Medicine (BCM)
2^nd Annual Center of Excellence in Health Equity, Training and Research Summer Research Summit in Houston, Texas (June 18, 2019)

• Baena E, Vuong KD, Stinson JM, McCauley SR, York MK, Strutt AM. Spanish/cross-cultural fellowship in neuropsychology: A response to the needs of the Houston Hispanic community. Presented at the Baylor College of Medicine (BCM), 2^nd Annual Center of Excellence in Health Equity, Training and Research Summer Research Summit in Houston, Texas (June 18, 2019).   [View poster]
• Strutt AM, Armendariz V, Vuong KD, Rossetti A. CCACTUS - Cross-cultural consortium on aging and cognition in Texas, U.S.: The development of a neuropsychology data repository. Presented at the Baylor College of Medicine (BCM), 2^nd Annual Center of Excellence in Health Equity, Training and Research Summer Research Summit in Houston, Texas (June 18, 2019).   [View poster]

Movement Disorder Society (MDS)
11^th International Congress of Parkinson's Disease and Movement Disorders in Istanbul, Turkey (June 3-7, 2007)

• Sitburana O, Rountree S, Vuong KD, Ondo W . Weight change in Parkinson and Alzheimer patients taking atypical antipsychotic drugs. Mov Disord. 2007;22 Suppl 16:S190.  [View poster]

Movement Disorder Society (MDS)
10^th International Congress of Parkinson's Disease and Movement Disorders in Kyoto, Japan (Oct. 30 - Nov. 2, 2006)

• Diamond AL, Vuong KD, Jankovic J. Deep brain stimulation of the subthalamic nucleus on Parkinson's disease: Effects on quality of life. Mov Disord. 2006;21 Suppl 15:S669.  [View poster]

American Neurological Association (ANA)
131^st Annual Meeting in Chicago, Ill. (Oct. 8-11, 2006)

• Diamond AL, Vuong KD, Jankovic J. Deep brain stimulation of the subthalamic nucleus on Parkinson's disease: Effects on quality of life. Ann Neurol. 2006;60 Suppl 10:S77. [Previously Presented]  [View poster]

American Academy of Neurology (AAN)
58^th Annual Meeting in San Diego, Calif. (April 1-8, 2006)

• Kenney CJ, Vuong K, Hunter C, Almaguer M, Jankovic J. Long term safety of deep brain stimulation for the treatment of Parkinson's disease. Neurology. 2006;66(5 Suppl 2):A49-50. 

American Academy of Neurology (AAN)
57^th Annual Meeting in Miami Beach, Fla. (April 9-16, 2005)

• Shahed J, Diamond AL, Vuong KD, Jankovic J. Characteristics of Parkinson's disease in patients with childhood-onset essential tremor. Neurology. 2005;64(6 Suppl 1):A255. [Previously Presented]  [View poster]

Movement Disorder Society (MDS)
9^th International Congress of Parkinson's Disease and Movement Disorders in New Orleans, La. (March 5-8, 2005)

• Azher SN, Vuong KD, Shahed J, Diamond AL, Jankovic J . Gait and balance assessment in parkinsonian disorders. Mov Disord. 2005;20 Suppl 10:S112-3.  [View poster]
• Diamond AL, Shahed J, Azher SN, Vuong KD, Jankovic J. Globus pallidus deep brain stimulation in dystonia. Mov Disord. 2005;20 Suppl 10:S153-4.  [View poster]
• Hunter C, Vuong KD, Mejia N, Jankovic J. Tetrabenazine: Does prior history of depression preclude this drug as a treatment option? Mov Disord. 2005;20 Suppl 10:S47.  [View poster]
• Mejia N, Vuong KD, Hunter C, Jankovic J. Medications associated with the onset of tardive dyskinesia. Mov Disord. 2005;20 Suppl 10:S18.  [View poster]
• Ondo WG, Meilak C, Vuong KD, Jankovic J. Predictors of battery life for the Activa® Soletra 7426 neurostimulator. Mov Disord. 2005;20 Suppl 10:S160-1.  [View poster]
• Shahed J, Diamond AL, Vuong KD, Jankovic J. Characteristics of Parkinson's disease in patients with childhood-onset essential tremor. Mov Disord. 2005;20 Suppl 10:S169-70.  [View poster]

American Neurological Association (ANA)
129^th Annual Meeting in Toronto, Canada (Oct. 4-5, 2004)

• Silay Y, Jankovic J, Vuong KD, Almageur M, Ondo WG, Tintner R, et al. The safety of deep brain stimulation in patients with Parkinson's disease, essential tremor, and other movement disorders. Ann Neurol. 2004;56 Suppl 8:S54-5.  [View poster]

Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders
18^th Annual Symposium in Toronto, Canada (Oct. 3, 2004)

• Jankovic J, Hunter CB, Vuong KD . Safety and efficacy of tetrabenazine in the treatment of Huntington's disease and other choreas. Mov Disord. 2004;19(9):1127.  [View poster]

Movement Disorder Society (MDS)
8^th International Congress of Parkinson's Disease and Movement Disorders in Rome, Italy (June 13-17, 2004)

• Hunter C, Vuong KD, Mejia N, Jankovic J . Tetrabenazine, a monoamine depleter, effective in the treatment of Tourette syndrome. Mov Disord. 2004;19 Suppl 9:S437.  [View poster]
• Jankovic J, Hunter C, Mejia N, Vuong KD. Tetrabenazine: Effective treatment for tardive dyskinesia. Mov Disord. 2004;19 Suppl 9:S73.  [View poster]
• Silver GA, Vuong KD, Jankovic J. Young-onset versus late-onset Parkinson's disease: Clinical features and disease progression. Mov Disord. 2004;19 Suppl 9:S264.  [View poster]
• Thomas M, Banuelos P, Vuong KD, Jankovic J. Long-term prognosis of psychogenic movement disorders. Mov Disord. 2004;19 Suppl 9:S431.  [View poster]
• Thomas M, Vuong KD, Jankovic J. Psychogenic dystonia: Clinical characteristics and long-term progression. Mov Disord. 2004;19 Suppl 9:S111.  [View poster]
• Vuong KD, Hunter C, Mejia N, Jankovic J. Safety and efficacy of tetrabenazine in childhood hyperkinetic movement disorders. Mov Disord. 2004;19 Suppl 9:S422.  [View poster]

American Academy of Neurology (AAN)
56^th Annual Meeting in San Francisco, Calif. (April 24 - May 1, 2004)

• Hunter CB, Vuong KD, Jankovic J. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Neurology. 2004;62(7 Suppl S5):A506-7.  [View poster]
• Jankovic J, Madisetty J, Vuong KD. Essential tremor in children. Neurology. 2004;62(7 Suppl S5):A502.  [View poster]
• Jankovic J, Vuong KD, Thomas M. Psychogenic tremor: Long-term outcome. Neurology. 2004;62(7 Suppl S5):A501.  [View poster]
• Silay YS, Vuong KD, Jankovic J . The efficacy and safety of fluphenazine in patients with Tourette syndrome. Neurology. 2004;62(7 Suppl S5):A506.  [View poster]

American Society for Experimental NeuroTherapeutics (ASENT)
6^th Annual Meeting in Bethesda, Md. (March 11-13, 2004)

• Jankovic J, Hunter CB, Vuong KD . Tetrabenazine in the treatment of chorea. Presented at the American Society for Experimental NeuroTherapeutics (ASENT), 6^th Annual Meeting in Bethesda, Md. (March 11-13, 2004).   [View poster]

American Academy of Neurology (AAN)
55^th Annual Meeting in Honolulu, Hawaii (March 29 - April 5, 2003)

• Ondo WG, Romanyshyn J, Vuong KD . Long term treatment of restless legs syndrome with dopamine agonists. Neurology. 2003;60(5 Suppl 1):A291.  [View poster]

Movement Disorder Society (MDS)
7^th International Congress of Parkinson's Disease and Movement Disorders in Miami, Fla. (Nov. 10-14, 2002)

• Hill AN, Jankovic J, Vuong KD, Donovan D . Treatment of hypophonia with collagen vocal fold augmentation in patients with parkinsonism. Mov Disord. 2002;17 Suppl 5:S105.  [View poster]
• Hunter CB, Wang A, Vuong KD, Jankovic J . Age-related tolerability of tetrabenazine. Mov Disord. 2002;17 Suppl 5:S41.  [View poster]
• Hunter CB, Wang A, Vuong KD, Jankovic J . Tetrabenazine in the treatment of Tourette syndrome. Mov Disord. 2002;17 Suppl 5:S341.  [View poster]
• Ondo WG, Wang A, Thomas M, Vuong KD . Evaluating factors that can influence spirography ratings in patients with essential tremor. Mov Disord. 2002;17 Suppl 5:S344.  [View poster]
• Tintner R, Almaguer M, Vuong KD, Ondo WG, Jankovic J, Sanghera M. Predictors of response to bilateral subthalamic nucleus stimulation for Parkinson's disease. Mov Disord. 2002;17 Suppl 5:S208. 

American Headache Society
44^th Annual Scientific Meeting in Seattle, Wash. (June 21-23, 2002)

• Ondo WG, Vuong KD, Derman HS. Botulinum toxin A (Botox) for chronic daily headache: A randomized placebo-controlled, parallel design study. Headache. 2002;42(5):414.  [View poster]

Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins
International Conference in Hannover, Germany (June 8, 2002)

• Jankovic J, Ahsan J, Vuong KD. Comparison of immunogenicity of old versus current Botox in cervical dystonia. Presented at the Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, International Conference in Hannover, Germany (June 8, 2002).   [View poster]

American Academy of Neurology (AAN)
53^rd Annual Meeting in Philadelphia, Penn. (May 5-11, 2001)

• Atassi F, Vuong KD, Jankovic J, Ondo WG. The prevalence of restless legs syndrome in patients with Parkinson's disease. Neurology. 2001;56(8 Suppl 3):A21. 
• Ondo WG, Vuong KD, Jankovic J. Exploring the relationship between Parkinson's disease and restless legs syndrome. Neurology. 2001;56(8 Suppl 3). 

Movement Disorder Society (MDS)
6^th International Congress of Parkinson's Disease and Movement Disorders in Barcelona, Spain (June 11-15, 2000)

• Ondo WG, Hunter C, Vuong KD, Jankovic J. Olanzapine treatment for dopaminergic induced hallucinations. Presented at the Movement Disorder Society (MDS), 6^th International Congress of Parkinson's Disease and Movement Disorders in Barcelona, Spain (June 11-15, 2000).  
• Ondo WG, Vuong KD, Atassi F, Khan H, Kwak C, Jankovic J. Daytime sleepiness in patients with Parkinson's disease. Presented at the Movement Disorder Society (MDS), 6^th International Congress of Parkinson's Disease and Movement Disorders in Barcelona, Spain (June 11-15, 2000).  

American Academy of Neurology (AAN)
52^nd Annual Meeting in San Diego, Calif. (April 29 - May 6, 2000)

• Vuong KD, Ondo WG, Almaguer M, Simpson RK, Jankovic J. Unilateral thalamic deep brain stimulation for essential tremor and Parkinson's disease: Effects of stimulation on the non-target limb and rebound augmentation. Neurology. 2000;54(Suppl 3):A54.